HotCopper.com on MSN17 天
Acrux scores fourth FDA approval, Nitroglycerin Ointment moving into commercialisation
Acrux Ltd (ASX:ACR) has been approved to begin U.S. commercialisation activities for its Nitroglycerin Ointment 0.4% ...